Cargando…
Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs
Cardiovascular diseases remain a major challenge for modern drug discovery. The diseases are chronic, complex, and the result of sophisticated interactions between genetics and environment involving multiple cell types and a host of systemic factors. The clinical events are often abrupt, and the dis...
Autores principales: | Kithcart, Aaron, MacRae, Calum A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113531/ https://www.ncbi.nlm.nih.gov/pubmed/30167552 http://dx.doi.org/10.1016/j.jacbts.2017.01.004 |
Ejemplares similares
-
Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007) -
Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023) -
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
por: Hendren, Nicholas S., et al.
Publicado: (2020) -
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021) -
Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023)